Targeting Human Papillomavirus to Reduce the Burden of Cervical, Vulvar and Vaginal Cancer and Pre-Invasive Neoplasia: Establishing the Baseline for Surveillance

• Mari Nygård ,

  * E-mail: mari.nygard@kreftregisteret.no

  Affiliation Department of Research, Cancer Registry of Norway, Oslo, Norway

  ⨯
• Bo Terning Hansen,

  Affiliation Department of Research, Cancer Registry of Norway, Oslo, Norway

  ⨯
• Joakim Dillner,

  Affiliation Departments of Laboratory Medicine, Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Christian Munk,

  Affiliation Unit of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark

  ⨯
• Kristján Oddsson,

  Affiliation The Cancer Detection Clinic, The Icelandic Cancer Society, Reykjavik, Iceland

  ⨯
• Laufey Tryggvadottir,

  Affiliations Icelandic Cancer Registry, Reykjavik, Iceland, Faculty of Medicine, Laeknagardur, University of Iceland, Reykjavik, Iceland

  ⨯
• Maria Hortlund,

  Affiliation Office for Medical Service, Department of Clinical Microbiology, Division of Laboratory Medicine, Region Skåne, Malmö, Sweden

  ⨯
• Kai-Li Liaw,

  Affiliation Department of Epidemiology, Merck Research Laboratories, North Wales, Pennsylvania, United States of America

  ⨯
• Erik J. Dasbach,

  Affiliation Health Economic Statistics, Merck Research Laboratories, North Wales, Pennsylvania, United States of America

  ⨯
• Susanne Krüger Kjær

  Affiliations Unit of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark, Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

  ⨯